FDA pushes back decision on Sanofi’s BTK inhibitor; Roche makes a deal with Starpharma

Plus, news about Sciwind Biosciences, Ipsen, Genfit, Ascletis, AusperBio, Ensoma, Jasper Therapeutics, Verrica, Incyte and Johnson & Johnson: 🏛️ FDA delays decision on Sanofi’s tolebrutinib: The company said that some additional ...